Teiji Takechi

Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats

Teiji Takechi, Koushi Nakano, Junji Uchida et al. · Cancer Chemotherapy and Pharmacology · 1996 · 162 citations

Medicine, Oncology, Pharmacology +9

Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.

Yoshiki Ishikawa, Tetsuro Kubota, Y Otani et al. · PubMed · 1999 · 120 citations

Medicine, Oncology, Pharmacology +13

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts

Hiroshi Tsukihara, Fumio Nakagawa, Kazuki Sakamoto et al. · Oncology Reports · 2015 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.

M Fukushima, Hirofumi Satake, Junji Uchida et al. · International Journal of Oncology · 1998 · 105 citations

Medicine, Oncology, Pharmacology +14

Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5‐Fluorouracil

Yoichiro Ishikawa, Tetsuro Kubota, Yoshihide Otani et al. · Japanese Journal of Cancer Research · 2000 · 93 citations · Full text

Medicine, Molecular Biology, Oncology +17